Immediate Impact
57 standout
Citing Papers
AXL signaling in cancer: from molecular insights to targeted therapies
2025 Standout
Cancer associated fibroblasts in cancer development and therapy
2025 Standout
Works of Miles E. Cameron being referenced
Phase II Study of 5-Fluorouracil, Oxaliplatin plus Dasatinib (FOLFOX-D) in First-Line Metastatic Pancreatic Adenocarcinoma
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Miles E. Cameron | 83 | 160 | 135 | 19 | 315 | |
| Dongxing Cao | 69 | 117 | 149 | 12 | 325 | |
| Jayan George | 77 | 79 | 117 | 23 | 318 | |
| Leszek Kraj | 92 | 98 | 63 | 28 | 356 | |
| Alessio Degiovanni | 106 | 121 | 58 | 23 | 341 | |
| Huairong Tang | 41 | 79 | 128 | 23 | 355 | |
| Kazuhito Oba | 32 | 93 | 73 | 23 | 343 | |
| Karla J. Suchacki | 45 | 117 | 137 | 19 | 344 | |
| Jia Zhang | 66 | 139 | 84 | 16 | 326 | |
| Yi Shen | 50 | 174 | 46 | 23 | 300 | |
| Xinbo Zhao | 39 | 152 | 41 | 26 | 361 |
All Works
Login with ORCID to disown or claim papers
Loading papers...